Brazili - Kireno - CPVS (Compêndio de Produtos Veterinários)

noxon do brasil quim farm ltda - vitamina b12; l-triptofano; cobre; Ácido cÍtrico; - probiÓticos

Brazili - Kireno - CPVS (Compêndio de Produtos Veterinários)

centralvet - glanzmann comercial imp exp ass., cons., marketing e rep. com. em veterinÁria ltda - vitamina a; vitamina b1; vitamina b12 (cianocobalamina); magnÉsio; manganÊs; ferro; enxÔfre; iodo; selÊnio; cobalto; cobre; vitamina e; zinco; - concentrado suplementar

Brazili - Kireno - CPVS (Compêndio de Produtos Veterinários)

dispec do brasil ind e com de prod agrop ltda - oxitetraciclina; cobalto; cobre; - antimicrobianos gerais; antifÚngicos e antiprotozoÁrios (coccidios, flagelados)

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

fresenius kabi brasil ltda - cloreto de zinco, cloreto fÉrrico, fluoreto de sÓdio, cloreto cÚprico, dicloreto de manganês tetraidratado, selenito de sÓdio, iodeto de potÁssio, cloreto crÔmico hexaidratado, molibdato de sódio diidratado - nutrientes parenterais

Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - outro aparelho digestivo e metabolismo produtos, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. o uso desta vacina deve ser de acordo com as recomendações oficiais.

Ureno - Kireno - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - deferasirox - comprimido revestido por película - 90 mg - deferasirox 90 mg - deferasirox - genérico - duração do tratamento: curta ou média duração

Ureno - Kireno - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - deferasirox - comprimido revestido por película - 360 mg - deferasirox 360 mg - deferasirox - genérico - duração do tratamento: curta ou média duração

Ureno - Kireno - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - deferasirox - comprimido revestido por película - 90 mg - deferasirox 90 mg - deferasirox - genérico - duração do tratamento: curta ou média duração

Ureno - Kireno - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - deferasirox - comprimido revestido por película - 90 mg - deferasirox 90 mg - deferasirox - genérico - duração do tratamento: curta ou média duração